Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998266911> ?p ?o ?g. }
- W2998266911 endingPage "905" @default.
- W2998266911 startingPage "895" @default.
- W2998266911 abstract "Abstract Receptor tyrosine kinase AXL is found upregulated in various types of cancer, including melanoma, and correlates with an aggressive cancer phenotype, inducing cell proliferation and epithelial-to-mesenchymal transition. In addition, AXL has recently been linked to chemotherapy resistance, and inhibition of AXL is found to increase DNA damage and reduce expression of DNA repair proteins. In light of this, we aimed to investigate whether targeting AXL together with DNA damage response proteins would be therapeutically beneficial. Using melanoma cell lines, we observed that combined reduction of AXL and CHK1/CHK2 signaling decreased proliferation, deregulated cell-cycle progression, increased apoptosis, and reduced expression of DNA damage response proteins. Enhanced therapeutic effect of combined treatment, as compared with mono-treatment, was further observed in a patient-derived xenograft model and, of particular interest, when applying a three-dimensional ex vivo spheroid drug sensitivity assay on tumor cells harvested directly from 27 patients with melanoma lymph node metastases. Together, these results indicate that targeting AXL together with the DNA damage response pathway could be a promising treatment strategy in melanoma, and that further investigations in patient groups lacking treatment alternatives should be pursued." @default.
- W2998266911 created "2020-01-10" @default.
- W2998266911 creator A5001914154 @default.
- W2998266911 creator A5026604844 @default.
- W2998266911 creator A5041567552 @default.
- W2998266911 creator A5053950619 @default.
- W2998266911 creator A5061915374 @default.
- W2998266911 creator A5066128117 @default.
- W2998266911 creator A5070137336 @default.
- W2998266911 creator A5072259697 @default.
- W2998266911 creator A5086860365 @default.
- W2998266911 creator A5088654429 @default.
- W2998266911 date "2020-03-01" @default.
- W2998266911 modified "2023-10-01" @default.
- W2998266911 title "Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma" @default.
- W2998266911 cites W1534535586 @default.
- W2998266911 cites W1540848543 @default.
- W2998266911 cites W1969717303 @default.
- W2998266911 cites W1977455794 @default.
- W2998266911 cites W1977937759 @default.
- W2998266911 cites W1980669461 @default.
- W2998266911 cites W1990134250 @default.
- W2998266911 cites W1992783176 @default.
- W2998266911 cites W2003445065 @default.
- W2998266911 cites W2013895149 @default.
- W2998266911 cites W2015023486 @default.
- W2998266911 cites W2020648103 @default.
- W2998266911 cites W2029304297 @default.
- W2998266911 cites W2040129575 @default.
- W2998266911 cites W2043841986 @default.
- W2998266911 cites W2047873619 @default.
- W2998266911 cites W2051165598 @default.
- W2998266911 cites W2052005627 @default.
- W2998266911 cites W2068973642 @default.
- W2998266911 cites W2070645893 @default.
- W2998266911 cites W2079075723 @default.
- W2998266911 cites W2103562758 @default.
- W2998266911 cites W2118374586 @default.
- W2998266911 cites W2121314233 @default.
- W2998266911 cites W2122375037 @default.
- W2998266911 cites W2122561635 @default.
- W2998266911 cites W2128841304 @default.
- W2998266911 cites W2129110050 @default.
- W2998266911 cites W2130200459 @default.
- W2998266911 cites W2132286757 @default.
- W2998266911 cites W2149542744 @default.
- W2998266911 cites W2149595959 @default.
- W2998266911 cites W2151406586 @default.
- W2998266911 cites W2158416296 @default.
- W2998266911 cites W2162730779 @default.
- W2998266911 cites W2168083201 @default.
- W2998266911 cites W2171749007 @default.
- W2998266911 cites W2299181842 @default.
- W2998266911 cites W2322789277 @default.
- W2998266911 cites W2327887515 @default.
- W2998266911 cites W2471709613 @default.
- W2998266911 cites W2524717494 @default.
- W2998266911 cites W2533710847 @default.
- W2998266911 cites W2547019108 @default.
- W2998266911 cites W2553952769 @default.
- W2998266911 cites W2561086413 @default.
- W2998266911 cites W2564267981 @default.
- W2998266911 cites W2564559465 @default.
- W2998266911 cites W2568917916 @default.
- W2998266911 cites W2592127988 @default.
- W2998266911 cites W2604532752 @default.
- W2998266911 cites W2735085100 @default.
- W2998266911 cites W2789194059 @default.
- W2998266911 cites W2884607428 @default.
- W2998266911 cites W2946108931 @default.
- W2998266911 doi "https://doi.org/10.1158/1535-7163.mct-19-0290" @default.
- W2998266911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31871265" @default.
- W2998266911 hasPublicationYear "2020" @default.
- W2998266911 type Work @default.
- W2998266911 sameAs 2998266911 @default.
- W2998266911 citedByCount "19" @default.
- W2998266911 countsByYear W29982669112020 @default.
- W2998266911 countsByYear W29982669112021 @default.
- W2998266911 countsByYear W29982669112022 @default.
- W2998266911 countsByYear W29982669112023 @default.
- W2998266911 crossrefType "journal-article" @default.
- W2998266911 hasAuthorship W2998266911A5001914154 @default.
- W2998266911 hasAuthorship W2998266911A5026604844 @default.
- W2998266911 hasAuthorship W2998266911A5041567552 @default.
- W2998266911 hasAuthorship W2998266911A5053950619 @default.
- W2998266911 hasAuthorship W2998266911A5061915374 @default.
- W2998266911 hasAuthorship W2998266911A5066128117 @default.
- W2998266911 hasAuthorship W2998266911A5070137336 @default.
- W2998266911 hasAuthorship W2998266911A5072259697 @default.
- W2998266911 hasAuthorship W2998266911A5086860365 @default.
- W2998266911 hasAuthorship W2998266911A5088654429 @default.
- W2998266911 hasBestOaLocation W29982669111 @default.
- W2998266911 hasConcept C101544691 @default.
- W2998266911 hasConcept C105696609 @default.
- W2998266911 hasConcept C121608353 @default.
- W2998266911 hasConcept C143425029 @default.
- W2998266911 hasConcept C150903083 @default.
- W2998266911 hasConcept C190283241 @default.